PAP治疗的第一印象对短期治疗坚持的影响
Monica Amendolara1, Valentina Di Lecce1, Carla Santomasi1
1Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University "Aldo Moro", 70124, Bari, Italy.
患者对阳性气道压力 (PAP) 治疗的看法显著影响阻断性睡眠呼吸暂停综合征 (OSAS) 的坚持. 解决早期的担忧可以改善长期的PAP使用和患者的结果.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统疗法 呼吸系统疗法
背景情况:
- 阳性气道压力 (PAP) 治疗是阻塞性睡眠呼吸暂停综合征 (OSAS) 的首要治疗方法.
- 较低的坚持率仍然是PAP治疗有效性的重大挑战.
- 患者的感知和接受是成功遵守PAP的关键因素.
研究的目的:
- 评估患者最初印象对PAP治疗坚持的影响.
- 为了评估患者在PAP治疗的最初六个月的感知和接受的变化.
- 确定与坚持相关的早期患者判断的关键因素.
主要方法:
- 一项前性队列研究,涉及77%的高坚持患者.
- 使用六项问卷来评估患者在基线 (T0) 和随访 (T1-T4) 时的印象.
- 评估了耐受性,舒适性,压力,预期的益处和整体态度,与坚持相关 (≥4小时/晚).
主要成果:
- 77%的患者在六个月后实现了高坚持.
- 随着时间的推移,患者报告的结果,包括耐受性和感知到的好处,有所改善.
- 较高的舒适度,坚持可能性和整体判断的初始分数预测了更好的坚持.
结论:
- 患者对PAP治疗的初步判断是短期坚持治疗的重要预测因素.
- 早期干预以管理患者的不适和投诉可以提高PAP的坚持和感知.
- 提高患者接受度是优化OSAS治疗结果的关键.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
06:022-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
相关概念视频
Drug Therapy
Antianxiety Medications
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
The Placebo Effect
Psychosis: Goals of Pharmacotherapy
